Small Molecule Regulation of Phosphatase-Dependent Cell Signaling Pathways

Oncology Research

Volumn 13, Issue 6-10, 2002, Pages 347-352

  Lazo, John S ^a   Wipf, Peter ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cell signaling pathyways; Protein phosphatases; Small molecules

Indexed keywords

CHOLESTEROL DERIVATIVE; DA 3003 1; DYSIDIOLIDE; NSC 663284; NSC 672121; NSC 95397; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE; SULFIRCIN; UNCLASSIFIED DRUG; VITAMIN K GROUP; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR;

CANCER CELL; CELL BASED GENE THERAPY; CELL DIFFERENTIATION; CELL FREE SYSTEM; COMBINATORIAL CHEMISTRY; CONFERENCE PAPER; DNA PROBE; ENZYME BINDING; ENZYME REGULATION; ENZYME SPECIFICITY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IC 50; MACROMOLECULE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; SIGNAL DETECTION; SIGNAL PROCESSING; SIGNAL TRANSDUCTION; STEM CELL; BIOLOGICAL MODEL; CELL CYCLE; CELL TRANSFORMATION; CHEMICAL STRUCTURE; CLASSIFICATION; DRUG EFFECT; METABOLISM; PHYSIOLOGY; REVIEW;

ANTINEOPLASTIC AGENTS; CDC25 PHOSPHATASE; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; ENZYME INHIBITORS; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; SIGNAL TRANSDUCTION;

EID: 0038499543     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504003108748555     Document Type: Conference Paper

References (40)

1. Hunter, T.; Pines. J. Cyclins and cancer 11: Cyclin D and CDK inhibitors come of age. Cell 79:573-582; 1994.
2. Zolnierowicz, S.; Bollen, M. Protein phosphorylation and protein phosphatases. EMBO J. 19:483-488; 2000.
3. Tonks, N. K.; Neel, B. G. From form to function: Signaling by protein tyrosine phosphatases. Cell 87:365-368; 1996.
4. Denu, J. M.; Stuckey, J. A.; Saper, M. A.; Dixon, J. E. Form and function in protein dephosphorylation. Cell 87:361-364; 1996.
5. Zhang, Z. Y. Protein tyrosine phosphatases: Structure and function, substrate specificity, and inhibitor development. Annu. Rev. Pharmacol. Toxicol. 42:209-234; 2002.
6. Myers, M. P.; Andersen, J. N.; Cheng, A.; Tremblay, M. L.; Horvath, C. M.; Parisien, J. P.; Salmeen, A.; Barford, D.; Tonks, N. K. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276:47771-47774; 2001.
7. Pestell, K. E.; Ducruet, A. P.; Wipf, P.; Lazo, J. S. Small molecule inhibitors of dual specificity protein phosphatases. Oncogene 19:6607-6612; 2000.
8. Millar, J. B.; Blevitt, J.; Gerace, L.; Sadhu, K.; Featherstone, C.; Russell, P. p55CDC25 is a nuclear protein required for the initiation of mitosis in human cells. Proc. Natl. Acad. Sci. USA 88:10500-10504; 1991.
9. Borgne, A.; Meijer, L. Sequential dephosphorylation of p34cdc2on Thr-14 and Tyr-15 at the prophase/metaphase transition. J. Biol. Chem. 271: 27847-27854; 1996.
10. cdc13 protein kinase. Anticancer Res. 12:873-880; 1992.
11. Wegener, S.; Hampe, W.; Herrmann, D.; Schaller, H. C. Alternative splicing in the regulatory region of the human phosphatases Cdc25A and Cdc25C. Eur. J. Cell Biol. 79:810-815; 2000.
12. Forrest, A. R.; McCormack, A. K.; DeSouza, C. P.; Sinnamon, J. M.; Tonks, I. D.; Hayward, N. K.; Ellem, K. A.; Gabrielli, B. G. Multiple splicing variants of cdc25B regulate G2/M progression. Biochem. Biophys. Res. Commun. 290:510-515; 1999.
13. Xu, X.; Burke, S. P. Roles of active site residues and the NH2-terminal domain in the catalysis and substrate binding of human Cdc25. J. Biol. Chem. 271:5118-5124; 1996.
14. Hoffman, I.; Draetta, G.; Karsenti, E. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 13:4302-4310; 1994.
15. Draetta, G.; Eckstein, J. Cdc25 protein phosphatases in cell proliferation. Biochim. Biophys. Acta 1332:M53-M63; 1997.
16. Baldin, V.; Cans, C.; Superti-Furga, G.; Ducommun, B. Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control. Oncogene 14:2485-2495; 1997.
17. Mailand, N.; Falck, J.; Lukas, C.; Syljuasen, R. G.; Welcker, M.; Lukas, J. Rapid destruction of human Cdc25A in response to DNA damage. Science 288:1425-1429; 2000.
18. Peng, C. Y.; Graves, P. R.; Thoma, R. S.; Wu, A.; Shaw, A. S.; Piwnica-Worms, H. Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277:1501-1505; 1997.
19. Sanchez, Y.; Wong, C.; Thoma, R. S.; Richman, R.; Wu, Z.; Piwnica-Worms, H.; Elledge, S. J. Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25. Science 277:1497-1501; 1997.
20. Xia, K.; Lee, R. S.; Narsimhan, R. P.; Mukhopadhyay, N. K.; Neel, B. G.; Roberts, T. M. Tyrosine phosphorylation of the proto-oncoprotein Raf-1 is regulated by Raf-1 itself and the phosphatase Cdc25A. Mol. Cell. Biol. 19:4819-4824; 1999.
21. Jinno, S.; Suto, J.; Nagata, A.; Igarashi, M.; Kanaoka, Y.; Nojima, H.; Okayama, H. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13:1549-1556; 1994.
22. Molinari, M.; Mercurilo, C.; Dominguez, J.; Goubin, F.; Draetta, G. F. Human Cdc25 A inactivation is response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep. 1:71-79; 2000.
23. cdc2. Cell 67:197-211; 1991.
24. Gabrielli, B. G.; De Souza, C. P. C.; Tonks, I. D.; Clark, J. M.; Hayward, N. K.; Ellem, K. A. O. Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J. Cell Sci. 109:1081-1093; 1996.
25. Zeng, Y.; Piwnica-Worms, H. DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding. Mol. Cell. Biol. 19:7410-7419; 1999.
26. Blasina, A.; de Weyer, I. V.; Laus, M. C.; Luyten, W. H.; Parker, A. E.; McGowen, C. H. A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase. Curr. Biol. 9:1-10; 1999.
27. Furnari, B.; Rhind, N.; Russell, P. Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 277:1495-1497; 1997.
28. Galaktionov, K.; Lee, A. K.; Eckstein, J.; Draetta, G.; Meckler, J.; Loda, M.; Beach, D. CDC25 phosphatases as potential human oncogenes. Science 269:1575-1577; 1995.
29. Hernandez, S.; Bessa, X.; Bea, S.; Hernandez, L.; Nadal, A.; Mallofre, C.; Muntane, J.; Castells, A.; Fernandez, P. L.; Cardesa, A.; Campo, E. Differential expression of cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma. Lab. Invest. 81:465-473; 2001.
30. Wu, W.; Fan, Y.-H.; Kemp, B. L.; Walsh, G.; Mao, L. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc. Cancer Res. 58:4082-4085; 1998.
31. Galaktionov, K.; Jessus, C.; Beach. D. Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev. 9:1046-1058; 1995.
32. Vogt, A.; Adachi, T.; Ducruet, A. P.; Chesebnrough, J.; Nemoto, K.; Carr, B. I.; Lazo, J. S. Spatial analysis of key signaling proteins by high-content solid-phase cytometry in Hep3B cells treated with an inhibitor of Cdc25 dual specificity phosphatases. J. Biol. Chem. 276:20544-20550; 2001.
33. Zou, X.; Tsutsui, T.; Ray, D.; Blomquist, J. F.; Ichijo H.; Ucker, D. S. ; Kiyokawa, H. The cell cycle-regulatory Cdc25A phosphatase inhibits apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 21:4814-4828; 2001.
34. Ma, Z. Q.; Liu, Z.; Ngan, E. S.; Tsai, S. Y. Cdc25B functions as a novel coactivator for the steriod receptors. Mol. Cell. Biol. 21:8056-8067; 2001.
35. Lazo, J. S.; Nemoto, K.; Pestell, K. E.; Cooley, K.; Southwick, E. C.; Mitchell, D. A.; Furey, W.; Gussio, R.; Zaharevitz, D. W.; Joo, B.; Wipf, P. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors. Mol. Pharmacol. 61:720-728; 2002.
36. Fauman, E. B.; Cogswell, J. P.; Lovejoy, B.; Rocque, W. J.; Holmes, W.; Montana, V. G.; Piwnica-Worms, H.; Rink, M. J.; Saper, M. A. Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A. Cell 93:617-625; 1998.
37. Reynolds, R. A.; Yem, A. W.; Wolfe, C. L.; Deibel, J. M. R.; Chidester, C. G.; Watenpaugh, K. D. Crystal structure of the catalytic subunit of Cdc25B required for G2.M phase transition of the cell cycle. J. Mol. Biol. 293: 559-568; 1999.
38. Rudolph, J.; Epstein, D. M.; Parker, L.; Eckstein, J. Specificity of natural and artifical substrates form human Cdc25A. Anal. Biochem. 289:43-51; 2001.
39. Lazo, J. S.; Aslan, D. C.; Souhwick, E. C.; Cooley, K. A.; Ducruet, A. P.; Joo, B.; Vogt, A.; Wipf, P. Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25. J. Med. Chem. 44:4042-4049; 2001.
40. Tamura, K.; Southwick, E. C.; Kerns, J.; Rosi, K.; Carr, B. I.; Wilcox, C.; Lazo, J. S. Cdc25 inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue. Cancer Res. 60:1317-1325; 2000.